COMP <GO>
XYL vs BRK-A // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Xylem Inc. Common Stock New (NYSE) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: XYL 7
— BRK-A 8
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: XYL
LAST: $92.40 (+1.81%) • MKT CAP: $20.81B
options-implied-move
6.60%
LAST: $815,600.00 (-0.23%) • MKT CAP: $1.20T
options-implied-move
7.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XYL VS. BRK-A)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | XYL | BRK-A | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 38.50% | 41.00% | -2.50 | BRK-A | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.50% | 8.30% | +0.20 | XYL | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.2x | 12.7x | +0.50 | BRK-A | /valuation <GO> |
| Free Cash Flow Yield | 4.01% | 2.08% | +1.93 | XYL | /fcf-yield <GO> |
| Operating Margin | 13.50% | 33.00% | -19.50 | BRK-A | /operating-margins <GO> |
| Net Profit Margin | 10.60% | 27.10% | -16.50 | BRK-A | /net-margins <GO> |
| Revenue Growth (YoY) | 5.50% | -1.00% | +6.50 | XYL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.88% | 0.00% | +1.88 | XYL | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.28 | 3.02 | +0.26 | XYL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 6/9 | +3.00 | XYL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.60% | 7.30% | -0.70 | XYL | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 33.5 | 67.2 | -33.72 | BRK-A | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 1.13 | -0.22 | BRK-A | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.2x | 16.7x | +3.50 | BRK-A | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $20.81B | $1.20T | -$1.18T | BRK-A | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | XYL REV | BRK-A REV | XYL GROSS % | BRK-A GROSS % | XYL FCF | BRK-A FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.04B | $247.24B | 38.5% | 44.0% | $834.4M | $25.04B |
| FY 2024 | $8.56B | $249.71B | 37.5% | 44.0% | $877.7M | $11.62B |
| FY 2023 | $7.36B | $254.91B | 44.0% | 44.0% | $505.6M | $37.73B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XYL // BETA 0.91
BRK-A // BETA 1.13